Manufacturer of Controlled Substances; Notice of Registration, 28075 [E7-9619]

Download as PDF 28075 Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: May 9, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9639 Filed 5–17–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated January 23, 2007, and published in the Federal Register on January 30, 2007, (72 FR 4298), Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: pwalker on PROD1PC71 with NOTICES Drug Schedule Codeine-N-oxide (9053) ............... Difenoxin (9168) ........................... Dihydromorphine (9145) ............... Morphine-N-oxide (9307) ............. Norlevorphanol (9634) .................. Normorphine (9313) ..................... Tetrahydrocannabinols (7370) ..... Nabilone (7379) ............................ Alfentanil(9737) ............................ Amphetamine (1100) .................... Ecgonine (9180) ........................... Codeine (9050) ............................. Dextropropoxyphene, bulk(9273) Dihydrocodeine (9120) ................. Diphenoxylate (9170) ................... Diprenorphine (9058) ................... Etorphine HCL (9059) .................. Fentanyl(9801) ............................. Hydrocodone (9193) ..................... VerDate Aug<31>2005 17:06 May 17, 2007 I I I I I I I II II II II II II II II II II II II Jkt 211001 Drug Schedule Hydromorphone (9150) ................ Levo-alphacetylmethadol (9648) .. Levorphanol(9220) ....................... Meperidine (9230) ........................ Methadone (9250) ........................ Methadone intermediate (9254) ... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Metopon (9260) ............................ Morphine (9300) ........................... Opium extracts (9610) .................. Opium fluid extract (9620) ............ Opium tincture (9630) .................. Opium, granulated (9640) ............ Opium, powdered (9639) ............. Oxycodone (9143) ........................ Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Phenazocine (9715) ..................... Alfentanil(9737) ............................ Remifentanil (9739) ...................... Sufentanil(9740) ........................... Thebaine (9333) ........................... II II II II II II II II II II II II II II II II II II II II II II II The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Mallinckrodt Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9619 Filed 5–17–07; 8:45 am] Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: Drug Phenylacetone (8501) .................. Coca Leaves (9040) ..................... Opium, raw (9600) ....................... Poppy Straw (9650) ..................... Poppy Straw Concentrate (9670) Schedule II II II II II The company plans to import the listed controlled substances for the manufacture of controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Mallinckrodt Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Mallinckrodt Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: May 14, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–9635 Filed 5–17–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated February 5, 2007 and published in the Federal Register on February 12, 2007, (72 FR 6579), PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48947), Noramco Inc., Division of OrthoMcNeil, Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal, and by separate correspondence dated June 2, E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28075]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9619]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 23, 2007, and published in the Federal 
Register on January 30, 2007, (72 FR 4298), Mallinckrodt Inc., 3600 
North Second Street, St. Louis, Missouri 63147, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed in schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Difenoxin (9168)...........................  I
Dihydromorphine (9145).....................  I
Morphine-N-oxide (9307)....................  I
Norlevorphanol (9634)......................  I
Normorphine (9313).........................  I
Tetrahydrocannabinols (7370)...............  I
Nabilone (7379)............................  II
Alfentanil(9737)...........................  II
Amphetamine (1100).........................  II
Ecgonine (9180)............................  II
Codeine (9050).............................  II
Dextropropoxyphene, bulk(9273).............  II
Dihydrocodeine (9120)......................  II
Diphenoxylate (9170).......................  II
Diprenorphine (9058).......................  II
Etorphine HCL (9059).......................  II
Fentanyl(9801).............................  II
Hydrocodone (9193).........................  II
Hydromorphone (9150).......................  II
Levo-alphacetylmethadol (9648).............  II
Levorphanol(9220)..........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Metopon (9260).............................  II
Morphine (9300)............................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, granulated (9640)...................  II
Opium, powdered (9639).....................  II
Oxycodone (9143)...........................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Phenazocine (9715).........................  II
Alfentanil(9737)...........................  II
Remifentanil (9739)........................  II
Sufentanil(9740)...........................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
internal use and for sale to other companies.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Mallinckrodt Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Mallinckrodt Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-9619 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P